Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist: BN 52021.
Touvay
C
C
IHB-IPSEN Institute for Therapeutic Research, Paris, France.
Vilain
B
B
Taylor
J E
JE
Etienne
A
A
Braquet
P
P
D000707:Anaphylaxis / Q000276:immunology*; D000818:Animals; D001986:Bronchial Spasm / Q000139:chemically induced / Q000276:immunology; D004224:Diterpenes; D046934:Ginkgolides; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007783:Lactones; D008168:Lung / Q000187:drug effects / Q000276:immunology*; D008297:Male; D010936:Plant Extracts / Q000494:pharmacology*; D010972:Platelet Activating Factor / Q000276:immunology* / Q000494:pharmacology; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface / Q000187:drug effects* / Q000276:immunology; D043562:Receptors, G-Protein-Coupled
D004224:Diterpenes; D046934:Ginkgolides; D007783:Lactones; D010936:Plant Extracts; D010972:Platelet Activating Factor; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; C039351:platelet activating factor receptor; C045856:ginkgolide B